Sargent Investment Group, LLC Cytosorbents Corp Transaction History

Sargent Investment Group, LLC

$449 Million
Q1 2024

A detailed history of Sargent Investment Group, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Sargent Investment Group, LLC holds 1,366,319 shares of CTSO stock, worth $1.18 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,366,319

Previous 1,308,747 4.4%

Holding current value

$1.18 Million

Previous $1.45 Million 10.61%

% of portfolio

0.29%

Previous 0.32%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.86 - $1.07 $49,511 - $61,602	57,572 Added 4.4%	1,366,319 $1.3 Million
Q4 2023 Feb 05, 2024	BUY	$1.08 - $1.94 $55,834 - $100,296	51,699 Added 4.11%	1,308,747 $1.45 Million
Q3 2023 Nov 13, 2023	SELL	$1.86 - $4.03 $60,446 - $130,966	-32,498 Reduced 2.52%	1,257,048 $2.36 Million
Q2 2023 Jul 31, 2023	BUY	$2.37 - $3.65 $168,300 - $259,197	71,013 Added 5.83%	1,289,546 $4.63 Million
Q1 2023 May 02, 2023	BUY	$1.79 - $4.17 $419,576 - $977,448	234,400 Added 23.82%	1,218,533 $4.11 Million

Q4 2022 Jan 31, 2023	SELL	$1.03 - $1.63 $127,823 - $202,283	-124,100 Reduced 11.2%	984,133 $1.53 Million
Q3 2022 Oct 26, 2022	BUY	$1.39 - $2.46 $181,724 - $321,613	130,737 Added 13.37%	1,108,233 $2.03 Million
Q2 2022 Jul 26, 2022	BUY	$1.76 - $3.22 $264,204 - $483,373	150,116 Added 18.14%	977,496 $2.14 Million
Q1 2022 May 06, 2022	BUY	$2.88 - $4.23 $122,526 - $179,961	42,544 Added 5.42%	827,380 $2.64 Million
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $726,185 - $1.45 Million	-179,305 Reduced 18.6%	784,836 $3.29 Million
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $754,782 - $1.05 Million	107,826 Added 12.59%	964,141 $7.83 Million
Q2 2021 Aug 05, 2021	BUY	$7.55 - $9.42 $544,694 - $679,605	72,145 Added 9.2%	856,315 $6.47 Million
Q1 2021 May 04, 2021	BUY	$8.23 - $11.48 $910,114 - $1.27 Million	110,585 Added 16.42%	784,170 $6.81 Million
Q4 2020 Feb 10, 2021	SELL	$7.65 - $8.98 $146,520 - $171,993	-19,153 Reduced 2.76%	673,585 $5.37 Million
Q3 2020 Nov 12, 2020	SELL	$7.37 - $11.54 $52,083 - $81,553	-7,067 Reduced 1.01%	692,738 $5.52 Million
Q2 2020 Aug 11, 2020	BUY	$6.28 - $10.59 $1.43 Million - $2.42 Million	228,050 Added 48.34%	699,805 $6.98 Million
Q1 2020 May 12, 2020	BUY	$3.77 - $7.73 $771,907 - $1.58 Million	204,750 Added 76.68%	471,755 $3.65 Million
Q4 2019 Feb 11, 2020	BUY	$3.61 - $5.22 $126,350 - $182,700	35,000 Added 15.09%	267,005 $1.03 Million
Q4 2019 Jan 30, 2020	SELL	$3.61 - $5.22 $230,715 - $333,610	-63,910 Reduced 21.6%	232,005 $893,000
Q3 2019 Oct 29, 2019	SELL	$4.33 - $7.63 $164,518 - $289,901	-37,995 Reduced 11.38%	295,915 $1.49 Million
Q2 2019 Aug 12, 2019	BUY	$5.92 - $7.78 $271,372 - $356,635	45,840 Added 15.91%	333,910 $2.21 Million
Q1 2019 May 13, 2019	BUY	$6.82 - $8.56 $263,524 - $330,758	38,640 Added 15.49%	288,070 $2.18 Million
Q4 2018 Feb 12, 2019	BUY	$7.05 - $12.64 $1.76 Million - $3.15 Million	249,430 New	249,430 $2.02 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account

Sargent Investment Group, LLC Cytosorbents Corp Transaction History